United States · FDA National Drug Code directory
H3N2 Influenza Nosode 4449
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63083-4449_bc143fb1-d232-4a0e-bc1f-6eab849fb0e4
- Product NDC
- 63083-4449
- Form
- LIQUID
- Composition / generic term
- H3N2 Influenza Nosode
- Labeler
- Professional Complementary Health Formulas
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 19840815
- Source listing expiry
- 20271231
Source-listed ingredients
- INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) NEURAMINIDASE ANTIGEN (PROPIOLACTONE INACTIVATED) — 12 [hp_X]/59mL
These values do not establish equivalence or a dose recommendation.
Packages
- 59 mL in 1 BOTTLE, DROPPER (63083-4449-2) · 63083-4449-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →